NUSAP1 and cervical cancer: The results of these studies will not only contribute to our understanding of NUSAP1 to cervical cancer metastasis but will also lead to the characterization of specific tumor patients’ groups with NUSAP1 overexpression who may benefit from co-therapy of traditional treatment and XAV-939.